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Abstract
Background—Lack of techniques to assess maximal blood flow capacity thwarts the use of 
rodent models of arterial insufficiency to evaluate therapies for intermittent claudication. We 
evaluated femoral vein outflow (VO) in combination with stimulated muscle contraction as a 
potential method to assess functional hindlimb arterial reserve and therapeutic efficacy in a rodent 
model of subcritical limb ischemia.
Materials and methods—VO was measured with perivascular flow probes at rest and during 
stimulated calf muscle contraction in young healthy rats (Wistar Kyoto, WKY; lean Zucker, LZR) 
and rats with cardiovascular risk factors (Spontaneously Hypertensive, SHR; Obese Zucker, OZR) 
with acute and/or chronic femoral arterial occlusion. Therapeutic efficacy was assessed by 
administration of Ramipril or Losartan to SHR after femoral artery excision.
Results—VO measurement in WKY demonstrated the utility of this method to assess hindlimb 
perfusion at rest and during calf muscle contraction. While application to diseased models (OZR, 
SHR) demonstrated normal resting perfusion compared to contralateral limbs, a significant 
reduction in reserve capacity was uncovered with muscle stimulation. Administration of Ramipril 
and Losartan demonstrated significant improvement in functional arterial reserve.
Conclusion—The results demonstrate that this novel method to assess distal limb perfusion in 
small rodents with subcritical limb ischemia is sufficient to unmask perfusion deficits not apparent 
at rest, detect impaired compensation in diseased animal models with risk factors, and assess 
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therapeutic efficacy. The approach provides a significant advance in methods to investigate 
potential mechanisms and novel therapies for subcritical limb ischemia in pre-clinical rodent 
models.
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1. Introduction
Peripheral arterial disease (PAD) of the lower extremity is a significant and serious health 
problem associated with increased morbidity, mortality and decreased quality of life(1, 2). It 
afflicts ~8 million Americans(3), including ~20% of the population over age 55(4) and 
~60% of those ≥ 85 years(5, 6). Its prevalence is increasing significantly(7, 8) as the 
population lives longer with chronic disease and risk factors such as diabetes. 
Approximately 10–20% of the population with PAD eventually experience pain during 
walking (intermittent claudication, IC) due to arterial insufficiency or inadequate perfusion 
during increased metabolic demand(5, 9). Within 10 years of diagnosis with IC, 20 – 30% 
progress to critical limb ischemia (CLI) characterized by rest pain or tissue loss (ulceration 
or gangrene) generally in the foot. This number increases to 45 – 60% if the patients are 
diabetic(10).
Based upon these statistics, there is widespread agreement that PAD is a malady in need of 
new medical treatments. Indeed, the development of therapies to improve function and 
quality of life in all stages of PAD has been identified as a great and unmet medical need(11, 
12). While multiple clinical trials with CLI patients have been conducted in recent years, 
few clinical studies have focused on the much more prevalent condition of IC. Moreover, 
there is a significant lack of medications effective in relieving symptoms and improving 
function in claudicants(13). Recent clinical reports using Ramipril (12, 14) have 
demonstrated the potential of pharmacological therapy to significantly improve muscle 
function and perfusion in claudicants. While the results are impressive and promising, 
significant questions have been raised regarding mechanisms and drug specificity(13). 
Consequently, additional studies are warranted. Furthermore, appropriate pre-clinical studies 
could provide important direction and insight regarding mechanisms and novel treatments 
for claudicants. However, the evaluation of potential therapeutics to improve subcritical 
limb ischemia requires assessment of maximal blood flow capacity or flow reserve, and the 
lack of such techniques in small animal models is a major limitation for their use in 
preclinical studies(15–17).
The purpose of this study was to evaluate femoral vein outflow (VO) in combination with 
stimulated muscle contraction as a potential method to assess functional hindlimb arterial 
reserve and therapeutic efficacy in a small rodent model of subcritical limb ischemia. Distal 
femoral vein outflow was measured with ultrasound transit time perivascular flow probes at 
rest and during electrically stimulated skeletal muscle contraction to assess functional 
reserve capacity. We first established the potential utility of this technique in young, healthy 
rats. Then, rats with vascular risk factors and known impairments to vascular compensation 
were used to assess the ability of this technique to detect perfusion deficits that were not 
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apparent at rest. Finally, the ability of this method to assess potential therapeutic efficacy 
was tested in rats with risk factors that also received pharmacological therapy.
1. Methods
1.1 Animals
These animal studies were approved by the Indiana University School of Medicine 
Institutional Animal Care and Use Committee. The animal care was in compliance with the 
Guide for the Care and Use of Laboratory Animals. Only male animals were used to 
minimize variability in these experiments to assess the feasibility and utility of the venous 
outflow technique.
The first series of experiments were performed in young Wistar Kyoto rats (WKY, 8–10 
wks old) obtained from Harlan Laboratories, Inc. (Indianapolis, IN) to assess the feasibility 
of measuring venous outflow, in the right hindlimb 2 wks after femoral artery ligation 
(Ligated) and in the left limb before (Non-Occluded) and after acute clamping (Acute) of the 
distal femoral artery (Figure 1), both at rest and during electrically induced calf muscle 
contraction.
After establishing feasibility, the next experiments were performed to evaluate the utility of 
this technique to assess differences between the diseased models of obese Zucker rats (OZR, 
Charles River Laboratories, Wilmington, MA) and retired breeder Spontaneously 
Hypertensive rats (SHR, Harlan Laboratories Inc.) compared to lean, normotensive control 
rats (lean Zucker rats, LZR). The OZR and SHR were selected because they are the most 
common rat strains utilized in studies of hindlimb ischemia(18–31) and have disorders 
typically associated with vascular disease in humans. We used femoral artery excision in 
these animals as most previous studies in these strains have utilized this method to induce 
arterial insufficiency. In these animals, venous outflow was measured in both left and right 
hindlimbs at rest and during electrically induced calf muscle contraction, 2 wks after right 
femoral artery excision (Excised). In the left limb the measurements were made before 
(Non-Occluded) and after acute (Acute) clamping of the distal femoral artery (Figure 1).
The final set of rat experiments was conducted to evaluate the ability of the venous outflow 
technique to assess the efficacy of potential therapies. SHR were treated with renin-
angiotensin system suppressing agents because this class of drug has been shown to provide 
remarkable benefit to human claudicants with hypertension(12, 14) and has demonstrated 
similar effects in prior rodent studies(28, 32). Treatment was initiated 2 weeks after femoral 
artery excision and venous outflow was measured in the right hindlimb of SHR two weeks 
later (4 weeks post-excision).
Lastly, acute studies were performed in mice to evaluate the potential application of venous 
outflow studies during skeletal muscle stimulation in this species. Adult C57BL/6 mice ≥12 
weeks of age were obtained from an established colony.
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2.2 Model creation of arterial insufficiency
2.2.1 Femoral artery ligation in rats—In the initial studies to develop the protocol for 
the venous outflow method and test the feasibility of unmasking a perfusion deficit with 
electrically stimulated skeletal muscle contraction, a single ligation of the femoral artery was 
performed in WKY rats. Following induction of anesthesia with isoflurane, a transverse 
incision (~2 cm) was made below the right inguinal ligament. Under microscopic 
observation and using fine forceps, a short segment of the right femoral artery distal to the 
superficial circumflex iliac artery (Figure 1) was exposed, carefully isolated from the nerve 
and vein by placing tension only on the artery or surrounding fascia, and then ligated. 
Tissues were kept moist with sterile saline during the entire procedure. The skin incisions 
were then closed and the animals recovered.
2.2.2 Femoral artery excision in rats—Femoral artery excision results in a more robust 
model of arterial insufficiency and was used to allow comparison with previous studies of 
hindlimb vascular compensation in LZR, OZR, and SHR rodents(19, 21, 30). As described 
by Emanueli et al. (21), under anesthesia an incision was made from the inguinal ligament to 
the knee. With microscopic observation and using fine forceps to contact only the artery or 
surrounding fascia, the right femoral artery was exposed and isolated from the circumflex 
iliac artery to the saphenous and popliteal bifurcation. Both ends of this segment were 
ligated as well as all branches. The femoral artery was then excised, the incision closed, and 
the rats recovered. Tissues were kept moist with sterile saline during the entire procedure.
2.3 Pharmacological therapy
Three groups of SHR rodents with femoral artery excision, as described above, received 
untreated drinking water (controls) or water treated with Ramipril (Sigma Chemical Co.) or 
Losartan (kindly provided by Merck) at 0.2 μM and 0.6 mM, respectively, beginning 2 
weeks post-excision. Following treatment for two weeks, hindlimb flow studies were 
conducted to assess the effect of therapy.
2.4 Perfusion assessment
Laser Doppler perfusion imaging (LDPI, Model LD12-IR, Moor Instruments LTD, Millwey, 
UK) was performed of the plantar surface of the hind paws under gaseous anesthesia with 
isoflurane to monitor recovery following ligation, as previously reported(33).
Femoral venous outflow measurement during skeletal muscle contraction was performed as 
follows. Rats were anesthetized with intraperitoneal Nembutal (50 mg/kg) and supplemented 
as needed. A tail vein catheter was placed for hydration and administration of supplemental 
anesthetic infusion. In addition, a tracheostomy was established and mechanical ventilation 
initiated and maintained. A right common carotid artery line was placed for continuous 
monitoring of mean arterial pressure (MAP). The femoral vein was carefully dissected under 
microscopic observation using fine tipped forceps to touch only surrounding tissues. Zero or 
baseline flow values were established with the flow probe immediately adjacent to the vein. 
Without contacting the vein with the forcep tips, sutures were placed loosely around the vein 
and used to assist in positioning the vein within the perivascular ultrasound transit time flow 
probe (Transonic Flowprobe, Transonic Systems Inc., Ithaca, New York, USA). Femoral 
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vein flow measurements were recorded during both resting conditions and contraction-
induced hyperemia brought on by electrical stimulation. Measurements in the left limb were 
made both before and after acute clamping of the left femoral artery. For electrical 
stimulation, surgical suture needles were placed anterior to the Achilles tendons and within 
the medial thigh musculature on each limb and connected to an electrical stimulator (Grass 
SD9 Stimulator, Grass Technologies, West Warwick, RI, USA). A setting of 7.0 volts was 
used for these studies, with a duration of 0.6 milliseconds. Femoral venous outflow was 
continuously recorded at variable contraction frequencies for 3 minutes each.
2.5 Acute feasibility studies in mice
Mice were anesthetized to effect via isoflurane mixed with oxygen. Following a 1.5 cm 
incision in the overlying skin from the level of the epigastric artery to the inguinal ligament, 
the nerve, artery, and vein were gently separated with fine tip forceps while tension was 
placed on the surrounding fascia. Extreme care was taken to minimize contact of the vein 
and nerve. Loops of 6–0 silk suture were then placed around the artery and vein to facilitate 
placement of the vessel within the flowprobe (Transonic 0.5PSB nanoprobe) without 
damage. The flowprobe was attached to a micromanipulator to allow fine adjustments under 
microscopic observation to ensure the vein was completely unobstructed and that the artery 
was not compressed. After obtaining a baseline flow, 0.125mm silver wires (WPI, Inc.) were 
inserted into the gastrocnemius muscle (where it becomes visible below adductors) and at 
the same level on the opposite side of the saphenous vessels. After obtaining venous flow 
under baseline and stimulated levels, the femoral artery was occluded just distal to the origin 
of the superficial epigastric artery and measurement of baseline and stimulated flow was 
repeated.
2.6 Statistical analyses
All data are expressed as means (±SEM). The statistical methods used throughout this study 
involved 2-way repeated measures (within subject) ANOVA unless otherwise specified in 
text or legends. When the ANOVA indicated statistical significance between group 
differences, the Holm-Sidak method was used for pairwise multiple comparison procedures. 
Values of P < 0.05 were considered significant.
3. Results
Average body mass and mean arterial pressures for the various experimental groups are 
reported in Table I. Body mass and arterial pressures were higher in OZR than LZR and 
arterial pressure was reduced by Ramipril and Losartan treatment in the SHR.
3.1 Assessment of the technique in young healthy animals
3.1.1 Feasibility of measuring venous outflow from the lower limb—Figure 2A 
depicts results obtained in WKY with the transit time ultrasonic flow probe positioned first 
on the distal femoral vein and then on the artery of the same rat limb. The tracing shows 
virtually identical blood flows when measured in the artery and vein both at rest and during 
functional hyperemia induced by stimulated muscle contraction. Similar results were 
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observed in two animals and demonstrated the feasibility of assessing perfusion of the lower 
limb by measurement of venous outflow both at rest and during hyperemia.
3.1.2 Effect of femoral artery ligation on venous outflow—The tracings in Figure 
2B illustrate typical changes in venous outflow observed at rest and during skeletal muscle 
contraction at 6 Hz in the left hindlimb before (Non-Occluded) and after acute clamping 
(Acute) of the femoral artery and in the right limb 14 d post-ligation of the femoral artery. 
Average values for venous outflow at rest (0 Hz) are shown in the first set of bars in Figure 
2C. With acute clamping of the femoral artery, femoral vein blood flow at rest was reduced 
to 54±4.8% of the non-occluded value (P=0.004). Resting flow in the ligated limb was 
72±9.2% of the same animal control limb without femoral artery occlusion and tended to be 
different than the flow measured without arterial occlusion (P=0.065), but was not 
statistically different than the flow observed after acute clamping (P=0.21).
3.1.3 Effect of femoral artery ligation on contraction-induced hyperemia—The 
second through fourth sets of bars in Figure 2C show venous flow measurements as the 
skeletal muscle is contracted at 2, 6, and 12 Hz. Blood flow increased from rest at all 
stimulus levels in limbs without femoral artery occlusion (Non-Occluded). With acute 
clamping of the left femoral artery (Acute) and previous ligation of the right (Ligated), flow 
was significantly increased at 6 and 12 Hz; but the increase was substantially less than 
observed in the non-occluded condition. For example, paired comparisons of limbs within 
animals indicated that whereas blood flow in the control limb increased by 505±36.6% at 
maximal stimulation (12 Hz), it only increased 105±35.7% and 119±35.6% in acutely 
clamped and ligated limbs, respectively. The difference in femoral venous flow between the 
Acute and Ligated limbs is statistically significant during skeletal muscle contraction at 6 
and 12 Hz, indicating vascular compensation had occurred. Taken together, the data indicate 
that functional hyperemia in response to skeletal muscle contraction is severely limited with 
acute occlusion and at two weeks post-ligation.
3.1.4 Compensation to femoral artery ligation assessed by LDPI—Chronic 
compensation to femoral artery ligation in the young WKY as assessed by LDPI is shown in 
Figure 2D. LDPI demonstrated an initial drop in perfusion of the ligated limb to an average 
of 39±2.2% of the control limb on post-op day 1. Over the course of the study, perfusion in 
the ligated limb improved showing statistically significant increases from days 1 to 3 and 3 
to 7. The resting perfusion relative to the control limb reached a plateau at day 7 (65±1.7%) 
as there was no further increase at day 14 (67±3.9%, P=0.48). These results are similar to 
those obtained at rest with the venous outflow method, but provide no insight into the 
functional or maximal reserve capacity of limbs with arterial occlusion relative to control 
limbs.
3.2 Assessment of the technique in models of arterial disease
3.2.1 Compensation to femoral artery excision assessed by LDPI—The results of 
LDPI assessment of perfusion from 1 to 14 days post-excision are presented in Figure 3A. 
Two-way repeated measures ANOVA indicated statistically significant differences in all 
days post-op, but no differences between groups and no interaction (day x treatment group) 
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effect. On the first day post-excision, LDPI results show a ratio of experimental to control 
limb perfusion of 0.395 ±0.040, 0.345 ± 0.029 and 0.648 ± 0.060 for LZR, OZR, and SHR, 
respectively. By post-op day 14, perfusion had increased to a similar level in all groups.
3.2.2 Effects of femoral artery excision on venous outflow at rest and during 
contraction induced hyperemia—Average femoral vein flow is shown under resting 
conditions (0 Hz) and during muscle stimulation at 2 and 12 Hz for LZR, OZR and SHR in 
Figure 3 B, C, and D, respectively. In control limbs without femoral artery occlusion (Non-
Occluded), venous flow increased significantly during muscle contraction in all rats (LZR, 
OZR and SHR) and flow at 12 Hz was greater than 2 Hz. With acute femoral artery 
occlusion, venous flow at rest (0 Hz) was significantly depressed in all groups. Resting flow 
in the limbs with femoral artery excision was similar to flow in the non-occluded limb of all 
groups. Venous flow at rest was higher in the limbs with femoral artery excision than acute 
clamping in LZR and SHR, but not OZR (P=0.109). The skeletal muscle contraction 
component of the study revealed profound perfusion impairment in the limbs with both 
acute clamping and excision for all groups--; no increase in venous flow was observed after 
acute clamping during 2 or 12 Hz stimulation. With maximal stimulation (12 Hz), flow in 
limbs with femoral artery excision increased by 112 ± 22.6% in LZR, 22 ± 10.4% in OZR, 
and 104 ± 20.6% in SHR compared to 230 ± 42.7%, 161 ± 16.8%, and 255 ± 44.4% 
respectively for limbs without occlusion. In limbs with excision, the relative increases from 
rest were statistically greater in LZR than OZR. It is important to note that the very 
significant perfusion deficit in the chronic limbs was only apparent under hyperemic 
conditions. It should also be noted that while comparison of the limbs 2 weeks after femoral 
excision to limbs with acute clamping of the femoral artery indicate compensation has 
occurred, the degree of compensation is likely underestimated as the initial degree of arterial 
insufficiency would be less with acute clamping than femoral excision.
3.3 Assessment of therapeutic efficacy: Effects of Ramipril and Losartan Post-treatment 
on contraction-induced hyperemia in SHR limbs with femoral artery excision
To assess the effect of pharmacological therapies for enhancement of compensation to 
arterial occlusion, venous outflow with electrical stimulation studies were performed in the 
SHR hindlimbs using an angiotensin converting enzyme inhibitor (Ramipril) and an 
angiotensin type I receptor blocker (Losartan). Drug therapy was initiated 2 weeks after 
femoral artery excision and continued for 2 weeks. Results are presented in Figure 4. 
Resting venous flows were similar between all groups and were increased significantly in all 
groups from 0 to 2 Hz and 2 to12 Hz. Relative to the untreated group, flow during muscle 
contraction was significantly greater in the Ramipril treated group at 2 and 12 Hz and in the 
group receiving Losartan at 12 Hz. Comparison of the Ramipril and Losartan groups 
indicated a statistically significant difference at 12 (p=0.03) but not 2 Hz (p=0.10).
4. Discussion
In this work we have addressed the need for more robust methods for the assessment of 
vascular compensation in the hindlimb of small rodents which have near normal perfusion at 
rest, but demonstrate a suppressed ability to increase perfusion during muscle activity; a 
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condition referred to as subcritical limb ischemia. We have presented a novel combination 
of venous outflow and contraction-induced skeletal muscle hyperemia and demonstrated that 
this method is capable of unmasking substantial perfusion deficits that are not apparent at 
rest. Our results show the utility of this technique in identifying differences between healthy 
rats versus rats with vascular risk factors and in assessment of therapeutic efficacy. Specifics 
regarding the development of the technique and its advantages and limitations over existing 
methods as well as the potential significance of the results obtained in diseased rats are 
considered below.
4.1 Development and evolution of the model
Venous outflow has been utilized in previous studies with larger animals to assess vascular 
compensation to arterial occlusion. After external iliac artery occlusion in dogs, Coffman 
(34) assessed collateral blood flow and reactivity by measurement of external iliac venous 
outflow via a continuously recording rotameter. After confirming that arterial inflow 
equaled venous outflow in his model, he obtained venous outflow measurements at rest, 
during contraction of the thigh muscles by electrical field stimulation and with infusion of 
vasoactive substances. Sanne and Sivertsson in 1968 (35) utilized venous outflow assessed 
by an optical-drop method at rest and during maximal peripheral dilation to quantify 
vascular compensation to femoral artery ligation in the cat. Although not previously utilized 
for this purpose to our knowledge, the development and miniaturization of transit time 
ultrasound flow probes (36) has made it possible to perform similar venous outflow studies 
in the rat and mouse hindlimb(37–40). These probes have been shown to provide accurate 
measurements of volume flow on arteries and veins as determined by roller pumps and 
volume collections as well as microsphere and clearance techniques(36, 41–44). We have 
utilized this approach with electrical field stimulation, based on parameters previously 
shown to be specific to the skeletal muscle cells and motor neurons(45–47) to assess the 
capacity for functional hyperemia (i.e. increased perfusion with elevated metabolic demand). 
Our results (Figure 2) demonstrate that distal venous outflow and arterial inflow are 
equivalent and that this combination can provide a continuous, real-time measurement of 
flow throughout the period of hyperemia to allow determination of average, total, and peak 
blood flow for various stimulus levels. Both the extent of impairment and degree of 
compensation can be assessed by comparing the venous outflow of the control limb before 
and after acute clamping of the femoral artery to the chronic experimental limb within the 
same animal (Figure 2C). The results we obtained in young healthy animals are similar to 
what others have reported utilizing different methodologies. In the control limbs we 
observed venous flow to increase approximately 5-fold, which is similar to the magnitude of 
the increase measured by microsphere technique in the rat gastrocnemius muscle with 
peroneal nerve stimulation(16) and rabbit extensor digitorum longus muscle with electrical 
field stimulation(48). While direct comparisons of the experimental limb in the current and 
previous studies cannot be made due to differences in ligation models, anesthesia, as well as 
species and strains, all studies demonstrate that muscle contraction unmasks a perfusion 
deficit that is not apparent at rest.
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4.2 Application to Models with Arterial Disease
Investigators have realized the potential importance of utilizing animal models of vascular 
disease in studies of arterial insufficiency, with the hope of more closely approximating the 
human situation(49). We thus sought to apply our measurement techniques to two rodent 
models of disease; the OZR and the SHR. Both of these strains have been documented to 
have a sustained impairment in hindlimb perfusion relative to non-diseased control animals 
after femoral artery excision (21, 22, 30, 31). Unlike these previous studies, we did not 
observe a perfusion deficit under resting conditions after recovery in the experimental limb 
as assessed by either LDPI or venous flow measurements (Figure 3). This might be 
explained by subtle differences in the excision model or surgical technique and associated 
injury and/or the anesthetics used. Alternatively, LDPI in the hindlimb is characterized by 
significant variation between animals and even control groups within a study(50, 51). We 
did observe a significant flow impairment with electrical hindlimb stimulation in the 
experimental limb of WKY, LZR, OZR, and SHR. Furthermore, our data reveal that while 
LZR, OZR, and SHR all exhibited the ability to significantly increase flow during simulated 
exercise in the experimental limb with chronic femoral artery excision, the increase was 
significantly less in OZR and SHR than LZR. The results confirm the utility of the venous 
outflow method with electrical stimulation to unmask perfusion deficits and also suggest the 
method could be useful to investigate the mechanisms for impaired compensation in models 
of subcritical limb ischemia with vascular risk factors.
4.3 Evaluation of Therapeutic Assessment
Having established the existence of subcritical limb ischemia in the SHR and OZR, we next 
sought to determine if the venous outflow method could be utilized to assess potential 
therapeutic efficacy in a model of subcritical ischemia. We evaluated the effect of Ramipril 
in the SHR because angiotensin converting enzyme inhibitors have been shown to improve 
perfusion in the SHR hindlimb(21), promote collateral growth in the SHR mesentery(28), 
and more importantly improve pain free and maximal walking times in human 
claudicants(12). We also chose to evaluate the angiotensin type 1 receptor antagonist 
Losartan, as it is a commonly prescribed drug which might have positive or negative effects 
on vascular compensation to arterial occlusion(18, 52, 53). Our results (Figure 4) 
demonstrate that neither Losartan nor Ramipril treatment significantly altered resting 
perfusion, but both substantially enhanced blood flow during muscle contraction. It is also 
important to note that the therapies were initiated 2 weeks after arterial occlusion; a post-
occlusion time point at which previous rat studies have shown hindlimb perfusion to have 
reach a plateau (21, 24) and at which recovery to control limb resting perfusion was 
observed in the current study(Figure 3A). It is also significant that the work by Emanueli et 
al. in SHR with femoral artery excision(21) found no increase in capillary or arteriolar 
density with Ramipril treatment that produced improvement in resting perfusion assessed by 
LDPI. These data suggest that the primary compensation might occur by collateral 
compensation. Our work also suggests that Ramipril is more efficacious than Losartan, a 
result that could be explained by the effect of ACEI on nitric oxide bioavailability(54). The 
results clearly indicate that this approach can establish therapeutic efficacy even when not 
commenced until after adaptations have restored resting perfusion to control levels. This 
addresses a major concern regarding whether efficacy of an intervention can be determined 
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if it is not administered before significant compensation has occurred(15) and also indicates 
an urgent need for additional studies to identify the specific mechanisms through which the 
benefits of Ramipril therapy is mediated.
4.4 Advantages and limitations
In their review of models and techniques for preclinical studies of peripheral arterial disease, 
Waters et al. (15) provided both general and specific recommendations which we considered 
in the development of our method. A major recommendation related to the need for 
measurement of collateral-dependent blood flow was direct measurement of blood flow to 
the distal hindlimb during local dilation so that the dominant resistance was that of the 
collateral circuit. However, there is currently no ideal method to assess collateral dependent 
perfusion in small rodents.
Lofti et al. (55) have reviewed the perfusion assessment methods that have been used in 
studies of hindlimb ischemia including LDPI, arterial flow probes, and microspheres. LDPI 
is the most commonly used technique for perfusion and offers major advantages in that it is 
non-invasive, can be used for longitudinal studies, and is relatively easy to learn(55). 
However, it is primarily used for assessment of resting flows and is considered to be 
inadequate to assess vascular reserve or collateral function/adaptation(15, 56). While 
Corcoran et al. (17) have attempted to assess reserve flow with LDPI by arterial occlusion to 
induce reactive hyperemia, an increase of only ~60% was observed in the control limb, 
which is far less than the normal flow reserve for skeletal muscle (16, 57–59). While LDPI 
can provide a perfusion index of the ischemic tissues relative to control limbs, the time 
required for the scan and the artifactual movement of red blood cells would preclude its use 
during muscle contraction, and thus in assessing peak functional hyperemia. In addition, 
LDPI provides only a measurement of the most superficial tissues and may not represent 
whole limb and especially deep muscles.
Microspheres have been considered the gold standard for measurement of blood flow and 
can provide measurement of flow in all individual muscles. They have been successfully 
used in rat hindlimb models of arterial insufficiency, represent an outstanding method to 
assess muscle perfusion(16), and can be utilized in unanesthetized animals during treadmill 
running(60). However, the microsphere technique also has limitations(16), including: 
processing time, potential loss and variability, and difficulties with the technique related to 
consistency and interpretation of results when applied to a rat hindlimb model of 
ischemia(61). It also is invasive, technically challenging(55), and does not permit real time 
or longitudinal studies. In addition, collection of the reference blood samples necessary to 
provide absolute perfusion values may not be possible in small rodents.
In this study, we elected to evaluate the venous outflow method in combination with local 
skeletal muscle stimulation as an alternative technique to assess flow capacity or functional 
reserve. Our results with the venous outflow technique demonstrate it to be highly 
reproducible and sufficient to detect differences in flow capacity during various levels of 
stimulation between healthy rodents and those with vascular risk factors, and also capable of 
assessing the efficacy of different therapies. Placement of the flow probe on the femoral vein 
draining the calf muscles (Figure 1) minimizes the contribution of flow from muscles 
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outside the collateral-dependent region. This was a major criticism of previous studies which 
measured flow in major inflow arteries proximal to the site of arterial ligation(15). While 
some of the measured venous flow may originate from the distal thigh muscles outside the 
collateral dependent region, the contribution during exercise is minimized by selective 
contraction of the calf muscles. Furthermore, any contribution from the thigh muscles would 
lead to an overestimate of calf perfusion which should also be present in the control limb. 
Our studies demonstrate that lower limb maximal perfusion remains suppressed and that the 
venous outflow technique is capable of unmasking perfusion deficits consistent with what 
has been reported with microspheres in calf muscles(16). However, the method is invasive 
and requires surgical training and experience to prevent complications including vascular 
injury. We did not experience complications and others have reported successful acute and 
chronic utilization of the miniature flow probes on the mouse artery(37–40). Our 
preliminary studies in the mouse (Figure 5) suggest that the venous outflow technique could 
be utilized in this species as well.
4.5 Conclusion and Future application
In conclusion, we have presented the measurement of venous outflow with transit time 
ultrasound flow probes during electrically stimulated contraction of calf muscles as a novel 
method to assess flow capacity in the distal limb of small rodents with subcritical limb 
ischemia. The method is demonstrated to be highly reproducible and sufficient to unmask 
perfusion deficits that are not apparent at rest and can be utilized to assess responses to 
different stimulus levels that might represent mild to intense skeletal muscle activity. It is 
capable of detecting impaired compensation in animal models of arterial disease and 
assessing therapeutic efficacy, including when such therapy is not initiated until after a 
stable response to the occlusive insult is achieved. The novel approach provides an 
alternative to the existing techniques including LDPI which provides longitudinal studies but 
cannot assess functional flow capacity and microspheres which some investigators have 
found difficult to adapt to small rodents. The venous outflow method combined with 
stimulation of calf muscle contraction provides a new tool for the assessment of subcritical 
limb ischemia and may facilitate preclinical assessment of novel therapies in small rodents. 
We suggest that future applications of this technique should be combined with histological 
studies to assess muscular and microvascular adaptations, muscle function studies, and 
proximal and distal pressure measurements to assess hemodynamic significance of collateral 
vs. distal adaptations. Future studies should also include sham operated controls to establish 
the extent to which surgical manipulations during model creation influence results.
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Figure 1. 
Line drawing representing hindlimb models used in this investigation. Major branches of the 
iliac-femoral arterial system of the rat from its origin at the aortic trifurcation (tail artery not 
shown) to its division into the saphenous and popliteal arteries of the distal limb are 
represented. In all experiments, the left limb served as the control. This control limb was 
acutely occluded with a microvascular clamp approximately 5 mm distal to the inguinal 
ligament to determine the degree to which blood flow was compromised at rest and during 
skeletal muscle contraction. The femoral artery of the right limb was either ligated (WKY) 
at the same location where the clamp was applied to the control limb or ligated and excised 
in lean and obese Zucker and SHR rats to be consistent with previous studies.
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Figure 2. 
Development and validation of combined venous outflow and skeletal muscle stimulation to 
assess blood flow reserve. A. Typical tracings of femoral vein and artery blood flow from 
rest to contraction-induced hyperemia and recovery in WKY. B. Representative records of 
venous outflow before and during skeletal muscle contraction induced by electrical field 
stimulation in the left limb before (Non-Occluded) and after acute (Acute) femoral artery 
occlusion with microvascular clamp (left and center panels, respectively) and in the right 
limb with femoral artery ligation 2 weeks previous (Ligated) (right panel). C. Average 
venous outflow at rest and during graded contraction induced by electrical field stimulation. 
D. Average LDPI of experimental limb over time relative to same animal control limb.
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Figure 3. 
Comparison of laser Doppler perfusion imaging (LDPI, panel A) and venous outflow at rest 
and during stimulated muscle contraction in control, lean Zucker rats (LZR, panel B), obese 
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Zucker rats (OZR, panel C), and Spontaneously Hypertensive rats (SHR, panel D). Venous 
flow measurements were made 2 weeks following femoral artery excision.
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Figure 4. 
Effect of pharmacological therapy (Ramipril and Losartan) on blood flow reserve in the limb 
of SHR. Therapy was initiated 2 weeks after femoral artery excision and continued for two 
weeks at which time the flow measurements were performed.
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Figure 5. 
Application of the venous outflow and skeletal muscle stimulation technique in mice. A) 
Illustrates the increase in flow from 0.10 ml/min at rest to a peak of about 1.13 ml/min 
during 4 Hz stimulation for 2 min. The tracing in B) is a magnified continuation of that in A) 
and shows the initial drop in blood flow with acute ligation of the distal femoral artery, a 
slight recovery that would be expected with dilation of the vasculature, and a greatly 
suppressed hyperemic response with stimulation. Similar results were observed in acute 
experiments on 4 mice. In conclusion, the venous outflow protocol presented here is feasible 
in mice but is technically challenging and requires more work to fully quantify and validate 
the technique.
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Table 1
Average body mass and mean arterial pressure (MAP)
Size (n) Body Mass (g) MAP (mm Hg)
WKY 5 258±4.4 140±6.7
LZR 8 322±7.7 149±2.9
OZR 7 531±12.0 161±4.2
SHR 7 404±14.0 197±1.9
SHR + Ramipril 3 418±15.1 135±6.9
SHR + Losartan 4 398±20.2 161±4.7
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